Short Reads

Premium

Elliott Sigal, who joined Bristol-Myers Squibb as VP of applied genomics and worked his way up to senior vice president of drug discovery and exploratory development, has been named senior VP of global clinical and pharmaceutical development.

 

MDS Proteomics announced the hiring of two new VPs of drug discovery: Gregg Morin, previously with Geron, will be based at the Toronto headquarters; and Mark Scheideler, from GlaxoSmithKline, will work out of Odense, Denmark.

 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.